Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge
Objective. To analyze the therapeutic effects and organ rejection of anti-PD-1 immunotherapy or antivascular targeting therapy on patients with combined malignancies after organ transplantation. Methods. We collected retrospective studies on “post-transplantation, cancer, immunotherapy, and vascular...
Saved in:
Main Authors: | Bairu Shen, Zi Guo, Peng Huang, Minghua Tan, Xiaoshen Zhang, Siyao Lin, Changshan Song, Jiaqing Wang, Minqian Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/6440419 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
by: Sonja S. Mojsilovic, et al.
Published: (2021-01-01) -
Urachal Mucinous Cystic Tumor of Low Malignant Potential with Concurrent Sigmoid Colon Adenocarcinoma
by: Kelly Brennan, et al.
Published: (2019-01-01) -
Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
by: Xue Wang, et al.
Published: (2025-01-01) -
Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01) -
The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Delia Nelson, et al.
Published: (2014-01-01)